<ѻýҕl>Add-On Tucatinib Ups Survival in Breast Cancer With Brain Metsѻýҕl> TKI plus trastuzumab-capecitabine reduced risk of death by nearly half Jun 01, 2020
<ѻýҕl>HCQ Linked to Harm in Cancer Patientsѻýҕl> Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<ѻýҕl>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News'ѻýҕl> News, features, and commentary about cancer-related issues May 28, 2020
<ѻýҕl>New Clue to Anti-PD-L1 Activity in Breast Cancer?ѻýҕl> Survival benefit with durvalumab in patients with PDL1 copy number alteration May 26, 2020
<ѻýҕl>Five Days of G-CSF Adequate for Breast Cancer Chemoѻýҕl> Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
<ѻýҕl>Honing Chemo Use in Small Breast Tumorsѻýҕl> Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
<ѻýҕl>Talzenna Misses OS Endpoint in BRCA-Positive Breast Cancerѻýҕl> But PARP inhibitor improved patient-reported outcomes over standard therapy Apr 29, 2020
<ѻýҕl>Anti-PD-L1 Plus PARP Inhibitor Ups Response in Breast Cancerѻýҕl> Add-on treatment superior to chemo alone, but questions remain about cost, toxicity Apr 28, 2020
<ѻýҕl>Hormone Levels Tied to Future Breast Cancer Riskѻýҕl> "New avenues for exploration" in risk stratification Apr 24, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>Beyond CDK4/6 Inhibitors for HR-Positive Breast Cancerѻýҕl> Switching drugs, taking aim at different targets under investigation Mar 11, 2020
<ѻýҕl>Shannen Doherty's Stage IV Breast Cancerѻýҕl> "Beverly Hills, 90210" star says she's "petrified" Feb 20, 2020
<ѻýҕl>Bell Ringing Not So Joyous for Cancer Patients?ѻýҕl> Greater treatment-related distress for those who rang bell at end of treatment Feb 10, 2020
<ѻýҕl>Bad News on Anti-HER2 Heart Effectsѻýҕl> Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
<ѻýҕl>Oral Paclitaxel Bests IV Delivery in Advanced Breast Cancerѻýҕl> But high pill count, lengthy dosing schedule could prove to be problematic Dec 14, 2019
<ѻýҕl>Residual Breast Cancer Tool Highly Prognostic After Neoadjuvant Txѻýҕl> Tumor burden calculator predicted long-term outcomes in all breast cancer subtypes Dec 14, 2019
<ѻýҕl>Anti-CDK4/6 Fails to Top Chemo in HR-Positive MBCѻýҕl> Similar PFS with chemo, palbociclib plus exemestane or fulvestrant after progression on aromatase inhibitor Dec 13, 2019
<ѻýҕl>HRT Has 20-Year Impact on Breast Cancer Risksѻýҕl> Prospective data confirm long-term benefit with estrogen-only and harm with added progestin Dec 13, 2019
<ѻýҕl>Checkpoints Show Different Outcomes in Breast Cancerѻýҕl> Atezolizumab misses complete response benefit in triple negative patients Dec 13, 2019
<ѻýҕl>T-DM1 Falls Short as Less-Toxic Option for Early Breast Cancerѻýҕl> Promising efficacy but higher discontinuation rates and cost likely a deterrent Dec 13, 2019
<ѻýҕl>Edging Closer to OS Benefit With Novel Anti-HER2 Drugѻýҕl> Larger benefit with margetuximab in most common HER2 breast cancer phenotype Dec 12, 2019
<ѻýҕl>New Standard for Metastatic HER2 Breast Cancerѻýҕl> Consistent PFS, OS benefit with combination including oral HER2 inhibitor tucatinib Dec 11, 2019
<ѻýҕl>Study Suggests Viable Alternative to Mastectomy After In-Breast Recurrenceѻýҕl> Mastectomy rates low, good cancer control in selected patients Nov 21, 2019
<ѻýҕl>Sex Assault at Mt. Sinai; Pharma's MD Millionaires; Mammography Marketing Machineѻýҕl> This past week in healthcare investigations Oct 23, 2019
<ѻýҕl>Novel CDK 4/6 Inhibitor Fails in Triple Negative Breast Cancerѻýҕl> Misses primary endpoints but has unexpected key benefit Oct 01, 2019
<ѻýҕl>Neoadjuvant Anti-PD-1 Boosts pCR in TNBCѻýҕl> Favorable trend toward improved event-free survival in preliminary analysis Sep 30, 2019
<ѻýҕl>CDK 4/6 Inhibitors Boost OS in Advanced Breast Cancerѻýҕl> Abemaciclib, ribociclib should become first-line treatment in HR-positive/HER2-negative disease, expert says Sep 29, 2019
<ѻýҕl>Abemaciclib Offers Hope in HR+/HER2+Breast Cancerѻýҕl> Phase II monarcHER trial shows better PFS with abemaciclib-trastuzumab-fulvestrant Sep 29, 2019
<ѻýҕl>Wires or RFID Tags in Breast Cancer Excision?ѻýҕl> Women like the less obtrusive method, but small study doesn't quite settle question of whether there's a tradeoff Sep 24, 2019
<ѻýҕl>The Legacy of Henry Lynch, MDѻýҕl> Earlier this summer the legendary researcher passed, his contributions to cancer research are immeasurable Sep 01, 2019
<ѻýҕl>Good News on Nipple-Sparing Breast Surgeryѻýҕl> Korean study examined recurrence rates Aug 30, 2019
<ѻýҕl>Olivia Newton-John's Stage 4 Cancer Cannabis Managementѻýҕl> The singer and actress updates fans on her battle, but can marijuana help? Aug 22, 2019
<ѻýҕl>Total Chemo Dose Still Matters in Breast Cancerѻýҕl> Worse survival with cumulative dose Aug 20, 2019
<ѻýҕl>MRI Screening Finds More Breast Cancers, but at What Cost?ѻýҕl> Even breast cancer survivors may find it tough to sort out benefits and harms Jul 24, 2019
<ѻýҕl>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritisѻýҕl> Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
<ѻýҕl>Jury Out on Margetuximab in Advanced HER2+ Breast Cancerѻýҕl> One-month PFS boost, but certain subgroups may derive more benefit Jun 05, 2019
<ѻýҕl>Cancer Surgery Refusal Remains a Problemѻýҕl> Older, unmarried, African-American patients more likely to say 'no' Jun 04, 2019
<ѻýҕl>Dramatic OS Boost With Kisqali in Young Breast Ca Patientsѻýҕl> 'First study to demonstrate improved survival for a targeted therapy' in advanced disease Jun 02, 2019 video
<ѻýҕl>Hormones Tied to Increased Breast Cancer Risk for Trans Womenѻýҕl> Overall risk still lower than cisgender women, however, and small overall May 14, 2019
<ѻýҕl>Detailed Policy Cuts Opioid Use After Breast Ca Surgeryѻýҕl> 40% of women reported zero narcotic use after surgery May 03, 2019